ArticleInternational journal of molecular sciences2023

High-Dose Ambroxol Therapy in Type 1 Gaucher Disease Focusing on Patients with Poor Response to Enzyme Replacement Therapy or Substrate Reduction Therapy.

Majdolen Istaiti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.